n,n-dimethylarginine has been researched along with dinoprost in 14 studies
| Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (dinoprost) | Trials (dinoprost) | Recent Studies (post-2010) (dinoprost) |
|---|---|---|---|---|---|
| 2,216 | 228 | 1,221 | 11,554 | 940 | 1,936 |
| Protein | Taxonomy | n,n-dimethylarginine (IC50) | dinoprost (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.0025 | |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 0.0713 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.14 | |
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.3 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.14 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 4.2 | |
| Prostaglandin F2-alpha receptor | Bos taurus (cattle) | 0.14 | |
| Prostaglandin F2-alpha receptor | Homo sapiens (human) | 0.0139 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.216 | |
| Prostaglandin D2 receptor | Homo sapiens (human) | 4.5 | |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.287 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bode-Böger, SM; Böger, RH; Chowienczyk, PJ; Fisher, I; Jackson, G; McGing, E; Ritter, JM; Walker, HA | 1 |
| Becker, T; Frölich, JC; Klempnauer, J; Nashan, B; Rode, I; Tsikas, D | 1 |
| Böger, RH; Maas, R; Quispe-Bravo, S; Schwedhelm, E; Skamira, C | 1 |
| Bucciarelli, L; Ciabattoni, G; Clissa, C; Consoli, A; Davì, G; Devangelio, E; Ferroni, P; Formoso, G; Michetti, N; Santilli, F | 1 |
| Benndorf, R; Böger, RH; Förstermann, U; Kahl, L; Li, H; Lüneburg, N; Maas, R; Schwedhelm, E | 1 |
| Böger, RH; Galle, J; Pinnetti, S; Schwedhelm, E; Wanner, C | 1 |
| Cibor, D; Mach, T; Owczarek, D | 1 |
| Averna, M; Ciabattoni, G; Consoli, A; Davì, G; Di Fulvio, P; Formoso, G; Ganci, A; Lattanzio, S; Lauro, R; Miccoli, R; Patrono, C; Pulizzi, N; Santilli, F; Sbraccia, P | 1 |
| Berkoz, FB; Cengiz, DT; Doğan, BS; Donmez, A; Erdogan, N; Kucur, M; Topal, G | 1 |
| Everett, CJ; King, DE; Player, M | 1 |
| Mazur, P; Plicner, D; Sadowski, J; Undas, A | 1 |
| Georgianos, PI; Grekas, DM; Kapoulas, S; Makedou, A; Makedou, K; Raptis, V; Sarafidis, PA; Sioulis, A | 1 |
| Baylis, C; Cunningham, MW; Sasser, JM | 1 |
| Lu, XY; Sui, GG; Sun, ZL; Xiao, HB | 1 |
4 trial(s) available for n,n-dimethylarginine and dinoprost
| Article | Year |
|---|---|
Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance.
Topics: Administration, Oral; Angina Pectoris; Arginine; Dinoprost; Double-Blind Method; Endothelium, Vascular; Exercise; Exercise Test; F2-Isoprostanes; Forearm; Heart Rate; Humans; Injections, Intra-Arterial; Male; Middle Aged; Oxidative Stress; Regional Blood Flow; Vasodilation | 2001 |
Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Proteinuria; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan | 2008 |
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus.
Topics: Acarbose; Aged; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; CD40 Ligand; Diabetes Mellitus, Type 2; Dinoprost; Double-Blind Method; Enzyme Inhibitors; Female; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Italy; Lipid Peroxidation; Male; Middle Aged; P-Selectin; Platelet Activation; Postprandial Period; Thromboxane B2; Time Factors; Treatment Outcome | 2010 |
The impact of pioglitazone on ADMA and oxidative stress markers in patients with type 2 diabetes.
Topics: Academic Medical Centers; Arginine; Biomarkers; Cross-Over Studies; Diabetes Mellitus, Type 2; Dinoprost; F2-Isoprostanes; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Nitrates; Nitrites; Oxidative Stress; Pioglitazone; Prospective Studies; South Carolina; Thiazolidinediones; Time Factors; Treatment Outcome | 2012 |
10 other study(ies) available for n,n-dimethylarginine and dinoprost
| Article | Year |
|---|---|
Elevated plasma and urine levels of ADMA and 15(S)-8-iso-PGF2alpha in end-stage liver disease.
Topics: Adult; Aged; Arginine; Dinoprost; F2-Isoprostanes; Female; Humans; Kidney Failure, Chronic; Liver Diseases; Male; Middle Aged | 2003 |
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Benzimidazoles; Benzoates; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Endothelium, Vascular; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Oxidative Stress; Randomized Controlled Trials as Topic; Renal Insufficiency; Telmisartan; Tetrazoles; Valine; Valsartan | 2005 |
Soluble RAGE in type 2 diabetes: association with oxidative stress.
Topics: Arginine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dinoprost; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2007 |
Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia.
Topics: Adolescent; Adult; Aged; Arginine; Cyclic GMP; Dinoprost; Endothelium, Vascular; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Sex Factors | 2008 |
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases.
Topics: Adolescent; Adult; Aged; Arginine; Biomarkers; Case-Control Studies; Colitis, Ulcerative; Crohn Disease; Dinoprost; Female; Humans; Male; Middle Aged; Oxidative Stress; Young Adult | 2010 |
Asymmetric dimethylarginine (ADMA) levels are increased in patients with fibromyalgia: correlation with tumor necrosis factor-α (TNF-α) and 8-iso-prostaglandin F(2α) (8-iso-PGF(2α)).
Topics: Adult; Arginine; Dinoprost; Female; Fibromyalgia; Humans; Male; Middle Aged; Surveys and Questionnaires; Tumor Necrosis Factor-alpha | 2011 |
Asymmetric dimethylarginine and oxidative stress following coronary artery bypass grafting: associations with postoperative outcome.
Topics: Aged; Arginine; Coronary Artery Bypass; Dinoprost; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Postoperative Complications | 2014 |
Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease.
Topics: Adolescent; Adult; Aged; Arginine; Dinoprost; Disease Progression; Female; Glomerular Filtration Rate; Humans; Isoprostanes; Kidney Function Tests; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Polycystic Kidney, Autosomal Dominant; Young Adult | 2013 |
Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Arginine; Arterial Pressure; Dinoprost; Disease Models, Animal; Down-Regulation; Humans; Hypertension; Injections, Subcutaneous; Kidney; Liver; Male; NADPH Oxidases; Nitric Oxide; Oxidative Stress; Proteinuria; Rats, Sprague-Dawley; Recombinant Proteins; Relaxin; Thiobarbituric Acid Reactive Substances | 2014 |
Elevated Levels of ADMA Are Associated with Lower DDAH2 and Higher PRMT1 in LPS-Induced Endometritis Rats.
Topics: Amidohydrolases; Animals; Arginine; Dinoprost; Disease Models, Animal; Down-Regulation; Endometriosis; Female; Interleukin-6; Lipopolysaccharides; Peroxidase; Protein-Arginine N-Methyltransferases; Rats, Wistar; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Up-Regulation; Uterus | 2018 |